Cambridge Healthtech Institute’s Second Annual

New Frontiers in Gene Editing

Striving for Better Design, Precision, and Efficiency

March 10-11, 2016 | Hilton San Francisco Union Square | San Francisco, CA
Part of the 23rd International Molecular Medicine Tri-Conference

 

Gene editing is rapidly progressing from being a research/screening tool to one that promises important applications downstream in drug development, cell therapy and bioprocessing. Cambridge Healthtech Institute’s second annual symposium on New Frontiers in Gene Editing will bring together experts from all aspects of basic science and clinical research to talk about the progress being made in gene editing and how it’s being applied. Knowing the strengths and limitations of the different tools, how does one decide when to use the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas system, as opposed to Transcription Activator-Like Effector Nucleases (TALENs), zinc finger nucleases (ZFNs) and other systems? What is being done to overcome some of the inherent challenges with design, delivery and off-target effects, associated with each of these techniques? Experts from pharma/biotech, academic and government labs will share their experiences leveraging the utility of gene editing for diverse applications.

Who should attend: Students, Post-docs, Lab Technicians, Managers, Scientists, Clinicians, Team Leads, Directors and Executives from Pharma, Biotech, Academia, Government, Contract Research Labs and Technology Providers involved in Pathway Analysis, Target identification and Validation, Functional Screening, Biomarker Discovery, Translational and Clinical Research, and Gene/Cell Therapy

Topics will include, but are not limited to:

  • Comparing gene editing tools: CRISPRs, TALENs, ZFNs and more
  • Understanding mode-of-action
  • Designing enhanced specificity and efficacy
  • Engineering precision gene editing
  • Creating relevant cell lines and knock-out models for disease modeling
  • Streamlining gene editing for therapeutic applications
  • Tackling challenges with off-target effects
  • Exploring uses in stem cells and gene therapy

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is August 28, 2015.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Tanuja Koppal, Ph.D.,
Conference Director
Cambridge Healthtech Institute
E: tkoppal@healthtech.com

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com

Joseph Vacca (Companies L-Z)
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com

Premier Sponsors:  

Coyote

Elsevier   

Jackson Laboratory - small logo 

 NanoString2   

 Precision for Medicine 

SeraCare(2)

Silicon Biosystems

Thomson Reuters-Large